NF1 and neurofibromatosis type 1: For example, a recent RNA-seq study of 15 patients clinically diagnosed with Neurofibromatosis type 1 but negative NF1 testing, identified that 10 out of the 15 patients presented noncoding changes including deep intronic variants, transposon insertions causing noncanonical splicing, and a branch point variant [34].